| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 02/21/2008 | CA2660318A1 Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activit y and use thereof |
| 02/20/2008 | EP1888548A1 Compositions and methods of treating retinal disease |
| 02/20/2008 | EP1888547A1 Indane derivatives as modulators of ion channels |
| 02/20/2008 | EP1888546A1 Thiazole derivatives and use thereof |
| 02/20/2008 | EP1888545A1 Thiazole carboxylic acid anilides |
| 02/20/2008 | EP1888532A1 Heteroaroyl-substituted serine amides |
| 02/20/2008 | EP1888512A2 Chemical compounds |
| 02/20/2008 | CN101125835A N-[2-(3-phenyl-2-acryloylamino)ethylsulfony]-timonacic ester and preparation method for derivative thereof |
| 02/20/2008 | CN101125138A Inhibitors against the production and release of inflammatory cytokines |
| 02/20/2008 | CN100369904C 2-(replace- amino)-NOBS HIV prolease inhibitor |
| 02/20/2008 | CN100369903C Five-membered-ring compound |
| 02/20/2008 | CN100369902C N-alkoxide oxo-2-triazolidone derivative, its preparation and use |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/19/2008 | USRE40086 [4S-(4,12a alpha )]-4-(dimethylamino)-7-(substituted)-9-(substituted amino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12 a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamides; wide spectrum bactericides, including tetracycline-resistant strains; veterinary medicine |
| 02/19/2008 | US7332631 Fc receptor modulating compounds and compositions |
| 02/19/2008 | US7332608 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 02/19/2008 | US7332524 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/19/2008 | US7332518 Carboxamides as fungicides in agriculture |
| 02/19/2008 | US7332514 Dibenzylamine compound and medicinal use thereof |
| 02/19/2008 | US7332513 N-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-formamide for example; compound forms a naturally occurring metabolite when NO is released to slow or prevent drug tolerance; treating cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders |
| 02/19/2008 | US7332512 Halogenated nitrobutadienes for controlling animal pests |
| 02/19/2008 | US7332511 Vanilloid receptor ligands and their use in treatments |
| 02/19/2008 | US7332487 Nitrogen-containing 5-membered ring compound |
| 02/19/2008 | US7332354 bioconjugation; luciferins; biopolymer labels |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/14/2008 | WO2008019090A2 Agonists of the sphingosine-1-phosphate receptor |
| 02/14/2008 | WO2008018655A1 Novel thiazole-based compound and inhibitor of t-type calcium channel containing the same |
| 02/14/2008 | WO2008018544A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | WO2008017840A1 Cyclopentanecarboxylic acid derivatives and their use in the treatment of bacterial infectious diseases |
| 02/14/2008 | WO2008017827A2 Azole and thiazole derivatives and their uses |
| 02/14/2008 | WO2008017816A2 Chemical compounds |
| 02/14/2008 | WO2008017649A1 Substituted azolin-2-yl-amino compounds |
| 02/14/2008 | WO2008002570A3 Human protein tyrosine phosphatase inhibitors and methods of use |
| 02/14/2008 | WO2008002569A3 Human protein tyrosine phosphatase inhibitors and methods of use |
| 02/14/2008 | US20080039662 Isomerizing an alkyl cis-4-(alkylsulfonylamino)cyclohexanecarboxylate to form the trans isomer with a base (alkali metal lower alkoxide, hydride or amide) in an aprotic solvent (toluene); forming the free acid by hydrolysis; sulfonation of alkyl 4-aminocyclohexanecarboxylate with alkylsulfinyl chloride |
| 02/14/2008 | US20080039629 Benzothniazole compositions and their use as ubiquition ligation inhibitors |
| 02/14/2008 | US20080039611 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/14/2008 | US20080039511 Thiazole Compound and Use Thereof |
| 02/14/2008 | US20080039499 Chemical Compounds |
| 02/14/2008 | US20080039466 2-(3-Substituted-Aryl) Amino-4-Aryl-Thiazoles As Tyrosine Kinase Inhibitors |
| 02/14/2008 | US20080039464 Compounds Which Modulate The CB2 Receptor |
| 02/14/2008 | US20080039451 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 02/14/2008 | US20080039374 Cross-lined glycopeptide-cephalosporin antibiotics |
| 02/14/2008 | US20080039327 3-heterocyclyl-substituted benzoyl derivatives |
| 02/14/2008 | US20080038225 Triazolyl acyclic hepatitis c serine protease inhibitors |
| 02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | CA2659478A1 Isoform-selective hdac inhibitors |
| 02/13/2008 | EP1886693A1 Agent for regeneration and/or protection of nerves |
| 02/13/2008 | EP1885875A2 Luminogenic and fluorogenic compounds and methods to detect molecules or conditions |
| 02/13/2008 | EP1885720A2 4-(thiazol-2-ylthioalkyl)-pyrazoles and their use as herbicides |
| 02/13/2008 | EP1513796B1 Phenyloxyalkanoic acid derivatives as hppar activators |
| 02/13/2008 | EP1303272B1 Benzothiazole derivatives for the treatment of alzheimer's disease and parkinson's disease |
| 02/13/2008 | CN101124208A Novel heteroaryl acetamide |
| 02/13/2008 | CN101124201A Parp抑制剂 Parp inhibitors |
| 02/13/2008 | CN100368407C 2-aminobenzothiazoles as CB1 receptor inverse agonists |
| 02/12/2008 | US7329682 Method for inhibiting 5-lipoxygenase using a benzoxazole derivative |
| 02/12/2008 | US7329681 Inhibitors of IMPDH enzyme |
| 02/12/2008 | US7329680 Heterocycle substituted carboxylic acids |
| 02/12/2008 | CA2435297C Novel 1,4-diamino-2-(thiazol-2-yl)benzene derivatives and dyes containing said compounds |
| 02/12/2008 | CA2374737C Novel process for synthesis of heteroaryl-substituted urea compounds |
| 02/12/2008 | CA2280270C Acrylonitrile compounds, process for their production and pesticides containing them |
| 02/07/2008 | WO2008016692A2 Chemical compounds |
| 02/07/2008 | WO2008016674A1 Agonists of the sphingosine- 1- phosphate receptor (slp) |
| 02/07/2008 | WO2008015517A2 Ep2 agonists |
| 02/07/2008 | WO2008015340A2 Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapuetic application thereof |
| 02/07/2008 | WO2007142904A3 Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands |
| 02/07/2008 | WO2007140385A3 Thiazole compounds as cannabinoid receptor ligands and uses thereof |
| 02/07/2008 | US20080033024 Aryl amino acid derivatives as inhibitors for treating inflammation |
| 02/07/2008 | US20080033022 Inhibitors of c-Jun N-terminal kinases (JNK) |
| 02/07/2008 | US20080033015 Histone Deacetylase Inhibitors |
| 02/07/2008 | US20080033012 Enzyme inhibitors |
| 02/07/2008 | US20080032993 Substituted heterocyclic compounds |
| 02/07/2008 | US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 02/07/2008 | US20080032961 Therapy employing LXRalpha modolators |
| 02/07/2008 | US20080032960 PI3 kinase antagonists |
| 02/07/2008 | CA2659473A1 Chemical compounds |
| 02/06/2008 | EP1884514A1 Method for the resolution of 2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazol and intermediate compounds |
| 02/06/2008 | EP1883622A1 Substituted aryl oximes |
| 02/06/2008 | CN101119981A New benzothiazolesulfonamides |
| 02/06/2008 | CN101119980A New benzothiazolecarboxamides |
| 02/06/2008 | CN101119723A Thiazolium compounds and uses thereof |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
| 02/05/2008 | US7326790 Diphenylisoxazole compounds and hydro isomers thereof |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 02/05/2008 | US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide |
| 02/05/2008 | US7326732 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders |
| 02/05/2008 | US7326728 Modulators of glucocorticoid receptor, AP-1, and/or NF-κβ activity and use thereof |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
| 02/05/2008 | CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 02/05/2008 | CA2284977C 3,3-disubstituted propylamines, their use and preparation |
| 01/31/2008 | WO2008012010A1 Fused oxazoles & thiazoles as histamine h3- receptor ligands |
| 01/31/2008 | US20080027228 Substituted thioacetamides |
| 01/31/2008 | US20080027096 Novel Pharmaceutical Compositions |
| 01/31/2008 | US20080027067 Heterocyclic derivatives as modulators of ion channels |
| 01/31/2008 | US20080027042 Novel Aminopyridine Derivatives Having Aurora a Selective Inhibitory Action |
| 01/31/2008 | US20080027036 S1P receptor modulating compounds and use thereof |
| 01/31/2008 | US20080027001 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
| 01/31/2008 | US20080025915 Technetium-And Rhenium-Bis (Heteroaryl) Complexes, And Methods Of Use Thereof |